PBEvsLGHTETF Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Langar Global HealthTech ETF (LGHT) is part of the Healthcare Technology segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is less expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.85% for LGHT. PBE is up 2.54% year-to-date (YTD) with -$3M in YTD flows. LGHT performs worse with -17.78% YTD performance, and -$926K in YTD flows. Run a side-by-side ETF comparison of PBE and LGHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PBE vs LGHT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE LGHT | +1.33%-0.06% | +10.39%-8.22% | +2.54%-17.78% | +31.31%-19.78% | +34.96%n/a | +10.44%n/a |
| Flows | PBE LGHT | +$2M- | -$3M-$926K | -$3M-$926K | -$26M-$348K | -$56M- | -$45M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE LGHT | +19.82%+22.07% | +19.09%+18.75% | +20.14%n/a | +22.41%n/a |
| Max drawdown | PBE LGHT | -4.08%-12.34% | -11.70%-25.58% | -22.21%n/a | -34.74%n/a |
| Max drawdown duration | PBE LGHT | 16d87d | 156d228d | 324dn/a | 1540dn/a |
PBE | LGHT | |
Last sale 6/12/2026 at 1:30 PM | $84.10 | $8.21 |
| Previous close 06/11/2026 | $84.82 | $8.21 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PBE | LGHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PBE | LGHT | |
|---|---|---|
| Last price | $84.10 | $8.21 |
| 1D performance | -0.85% | +0.09% |
| AuM | $259.85 M | $2.38 M |
| E/R | 0.58% | 0.85% |
PBE | LGHT | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Langar Investment Management |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | - |
| N° of holdings | 30 | 24 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | January 10, 2024 |
| ESG | No | Yes |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
